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M E T H O D S  L E T T E R  T O  T H E  E D I T O R
Murine type VII collagen distorts outcome in human skin graft 
mouse model for dystrophic epidermolysis bullosa
Abstract
Human skin graft mouse models are widely used to investigate and 
develop therapeutic strategies for the severe generalized form of re-
cessive dystrophic epidermolysis bullosa (RDEB), which is caused by 
biallelic null mutations in COL7A1 and the complete absence of type 
VII collagen (C7). Most therapeutic approaches are focused on re-
introducing C7. Therefore, C7 and anchoring fibrils are widely used 
as readouts in therapeutic research with skin graft models. In this 
study, we investigated the expression pattern of human and murine 
C7 in a grafting model, in which human skin is reconstituted out of 
in vitro cultured keratinocytes and fibroblasts. The model revealed 
that murine C7 was deposited in both human healthy control and 
RDEB skin grafts. Moreover, we found that murine C7 is able to form 
anchoring fibrils in human grafts. Therefore, we advocate the use of 
human- specific antibodies when assessing the reintroduction of C7 
using RDEB skin graft mouse models.
1  | BACKGROUND
Dystrophic epidermolysis bullosa (DEB) is a monogenetic blistering 
skin disorder caused by mutations in the COL7A1 gene that encodes 
type VII collagen (C7). After post- transcriptional modifications, 
C7 assembles into anchoring fibrils (AFs) which secure attach-
ment of the lamina densa to the dermal matrix.[1] DEB is inherited 
either dominantly (DDEB; OMIM#131750) or recessively (RDEB;
OMIM#226600).[2]
Currently, there is no cure for DEB, and, therefore, there is a 
need for animal models for therapy development. Existing ani-
mal models comprise several spontaneously developed models of 
DEB in cat, dog, sheep and rat, but these are not C7 null models.[3] 
Spontaneous C7 null animals do not survive beyond the neona-
tal phase, and therefore, conditional knockout and hypomorphic 
mouse models have been developed.[4,5] However, these models 
suffer from residual C7 expression. Moreover, more than 700 dif-
ferent COL7A1 variants have been identified in DEB causing a wide 
variety of phenotypes, and models only exist for a few COL7A1 
mutations.[6,7] To circumvent these drawbacks, mouse models that 
tolerate human skin grafts are commonly used in DEB research, as 
they allow to directly test therapeutic approaches on patient skin 
and for specific mutations. Because the complete absence of C7 
is the cause of disease in the generalized severe recessive dystro-
phic epidermolysis bullosa (RDEB- gen sev) subtype, most thera-
peutic approaches are focussed on reintroducing C7 in patient skin. 
Expression of C7 and the presence of AFs in the grafts are therefore 
important readouts.
Because we noticed the presence of AFs in skin grafts generated 
out of human C7 null cells, we posed the question whether murine 
C7 is deposited at the basement membrane zone (BMZ) and could 
contribute to the formation of AFs seen in human skin grafts, which 
could seriously confound results obtained using such skin grafts.
2  | QUESTIONS ADDRESSED
We examined the presence and source of murine C7 in reconstituted 
human skin grafts grown on the back of mice. Thereby, we answer 
the question as to how human C7 expression should be analysed 
validly in grafting models.
3  | E XPERIMENTAL DESIGN
In the grafting model, skin equivalents were reconstituted in vivo 
within grafting chambers implanted on the back of mice from a ke-
ratinocyte/fibroblast cell suspension (see Supplementary Methods 
for details).[8] The model is well established and has recently been 
used in the context of therapy development for RDEB.[9]
Control grafts were generated using healthy human control 
skin cells and RDEB grafts using C7 null RDEB patient- derived skin 
cells (see Supplementary Methods for details). Biopsies were taken 
10 weeks postgrafting and subjected to immunofluorescence C7 
staining (IF) and ultrastructural imaging of AFs. The human- specific 
monoclonal antibody LH7.2 (Abcam, Cambridge, UK) and the mouse- 
specific polyclonal antibody AP23437PU (Acris, Herford, Germany) 
were used as primary antibodies against C7. Electron microscopy 
was performed on glutaraldehyde- fixed biopsies as previously de-
scribed.[10] Fluorescent in situ hybridization (FISH) using human 
X- chromosome and Y- chromosome probes (Abbott Molecular, Del 
Plaines, IL, USA) was used to distinguish human from murine cells.
© 2018 The Authors. Experimental DermatologyPublishedbyJohnWiley&SonsLtd.
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4  | RESULTS
IF using the LH7.2 antibody on control human and control murine 
skin confirmed specificity of LH7.2 for human C7; LH7.2 did not 
cross- react with murine C7 (Figure S1). Similarly, IF using the poly-
clonal AP23437PU antibody on control human and control mouse 
skin confirmed that the antibody is specific for murine C7 and does 
not cross- react with human C7.
IF for human C7 (LH7.2) showed brightly positive staining along 
the BMZ in control skin grafts (Figure 1). RDEB skin grafts re-
vealed the complete absence of human C7 staining, as expected. 
Surprisingly though, both control and RDEB skin grafts showed pos-
itive staining for murine C7 along the BMZ (Figure 1). In the RDEB 
skin grafts, the C7 deposition along the BMZ showed a widened pat-
tern, which correlated with staining for type IV collagen (C4), which 
is the major component of the lamina densa. This widening has been 
noticed before in RDEB patient skin grafts.[9]
To investigate the source of the observed murine C7 in these 
skin grafts, FISH using human X- chromosome and Y- chromosome 
probes was performed (Figure S2). First, to confirm the specificity 
of the probes, female and male healthy control skin sections were 
stained,inwhichmorethan95%ofdermalcellsmarkedpositive.In
contrast, mouse skin samples were completely negative, confirm-
ing the specificity of the probes. Subsequently, skin sections of re-
constitutedskingraftswereanalysed.Lessthan15%ofthedermal
cells of human female control grafts were positive for the human X- 
chromosome, whereas positive epidermal cell numbers were compa-
rable to control skin, indicating that murine dermal cells might have 
invaded the dermal tissue of the human skin graft. Haematoxylin 
and eosin staining substantiated this hypothesis (Figure S3). The re-
ticular dermis underneath the human graft resembled that of the 
surrounding murine skin and could be the result of wound healing by 
contraction of the murine skin. This suggests that at least a substan-
tial portion of the reticular dermis underneath the graft is composed 
of murine tissue and that, from there, murine fibroblasts invade the 
papillary dermis directly underneath the graft and are the source of 
the observed murine C7 in the graft.
Subsequently, transmission electron microscopy (TEM) was per-
formed to determine the presence of AFs (Figure 2). In control grafts, 
TEM revealed a well- defined papillary dermis and lamina densa. AFs 
were detected that were connected to the lamina densa, stretching 
into the papillary dermis. In RDEB grafts, widening of the lamina lu-
cida and lamina densa offshoots were observed reflecting patient 
skin. Connected to the lamina densa, however, AFs were detected, 
which should be of murine origin, as the grafts were completely neg-
ative for human C7 as seen by IF.
5  | CONCLUSIONS
Our results show that (a) murine C7 is deposited in human skin 
grafts, (b) this murine C7 is capable of forming AFs that attach to the 
lamina densa of the human skin graft, and (c) the C7 is most likely 
originating from murine fibroblasts, as our FISH data showed that 
mouse keratinocytes do not seem to invade the epidermis of the skin 
graft and previous studies have shown that normal human allogenic 
fibroblasts can also produce detectable C7 and AFs at the BMZ in 
RDEB skin.[9,11]
These results demonstrate that it is essential to distinguish 
human from murine C7 when C7 expression is used as outcome 
measurement, especially in preclinical studies using grafting mod-
els, as murine C7 can confound the interpretation of results. To 
do so, it is important to keep in mind that human and mouse C7 
are highly homologous,[12] and most polyclonal antibodies (eg the 
F IGURE  1  Immunofluorescence staining reveals mouse type 
VII collagen deposition in skin grafts. Healthy control skin graft 
and RDEB skin graft were positive and negative for human C7 (top 
row), respectively. All human skin grafts were positive for mouse 
C7 (middle row). Staining pattern in RDEB graft skin is fuzzy below 
the BMZ. The fuzziness of the BMZ especially in RDEB grafts was 
visualized by staining for pan- species type IV collagen (C4) (bottom 
row).NucleiarestainedbyDAPI.Barrepresents50μm
F IGURE  2 Ultramicrographs of the formation of AFs in in vivo 
reconstituted RDEB grafts. The lamina lucida and lamina densa 
were well defined and regular in mouse skin and healthy human 
control skin after grafting. RDEB graft skin revealed a lamina densa 
with downward offshoots (asterisk) and a lamina lucida of variable 
width. Interestingly, a five times higher magnification (lower panel) 
revealed the presence of anchoring fibrils (black arrows) projecting 
into the lamina densa in all samples, including the RDEB graft 
generated with C7- negative keratinocytes. Bar represents 1 μm
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widely used Calbiochem polyclonal rabbit- anti- human antibody) 
show cross- reactivity (Figure S4). Therefore, in case the origin of 
C7 is essential for the interpretation of results, we advocate the use 
of validated species- specific antibodies for IF and, whenever possi-
ble, to perform immunoelectron microscopy, as described by Keene 
and colleagues, to determine the exact origin of AFs.[13] Moreover, 
in functional studies into skin fragility of the RDEB graft area, if 
feasible, murine C7 should be taken into account due to possible 
reinforcement of the graft by murine C7 and formation of AFs.
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SUPPORTING INFORMATION
Additional supporting information may be found online in the 
Supporting Information section at the end of the article.
Figure S1 Confirmation of species- specificity of the human LH7.2 
and murine AP23437PU monoclonal antibodies. Healthy control 
mouse (left column) and human (right column) skin cryosections 
were stained with the LH7.2 (upper row) and AP23437PU (lower 
row) antibodies. Species specificity for human (LH7.2) and mouse 
(AP23437PU) was confirmed and no cross- reaction was observed
Figure S2 FISH staining suggests the presence of mouse fibroblasts 
in human skin grafts. FISH was performed on all samples with both 
human X- chromosome (green dot) and Y- chromosome (orange- red 
dot) probes. FISH performed on mouse control, human female con-
trol,andhumanmalecontrolskincryosections,revealed0%,more
than 95%, and more than 95% positive dermal cells, respectively
(upper row). Both dermal and epidermal cells of mouse skin were 
completely negative for both probes. A healthy female control skin 
graftsection(bottomrow),showedlessthan15%positivelylabelled
dermal cells, a representative image for all skin grafts stained. The 
white line in the lower right panel indicates the border between the 
human skin graft epidermis and the mouse epidermis. Percentages 
represent positive dermal cells in the image. Nonspecific binding ap-
peared as bright orange to yellow in all samples
Figure S3 Haematoxylin and Eosin staining of a healthy control skin 
graft. H/E staining shows a difference in density between the der-
mal tissue directly underneath and deeper underneath the skin graft. 
Mouse dermal tissue appears to have grown underneath the skin 
graft from the sides inwards. The image is a fusion of three images
Figure S4 Analysis of the species- specificity of the Calbiochem 
and LH7.2 antibodies. Cryosections from a control graft generated 
using the in vivo method were stained with the LH7.2 monoclonal or 
Calbiochem polyclonal anti- type VII collagen antibodies. The border 
between human graft and murine epidermis was identified in all sec-
tions (marked by white line) and imaged at comparable exposure times 
(~2 seconds) using a Leica IF microscope. Calbiochem (left) and LH7.2 
(right) staining reveals that the Calbiochem detects both murine and 
human C7 (green). In contrast, the LH7.2 antibody specifically detects 
human C7 (green). Nuclei are visualized using DAPI (blue)
Appendix S1 Supplementary Methods
